Vestibular functions at the Meniere's attack and after treatment
Project/Area Number |
21592159
|
Research Category |
Grant-in-Aid for Scientific Research (C)
|
Allocation Type | Single-year Grants |
Section | 一般 |
Research Field |
Otorhinolaryngology
|
Research Institution | The University of Tokyo |
Principal Investigator |
KAKIGI Akinobu 東京大学, 医学部附属病院, 講師 (60243820)
|
Project Period (FY) |
2009 – 2012
|
Project Status |
Completed (Fiscal Year 2012)
|
Budget Amount *help |
¥4,550,000 (Direct Cost: ¥3,500,000、Indirect Cost: ¥1,050,000)
Fiscal Year 2012: ¥780,000 (Direct Cost: ¥600,000、Indirect Cost: ¥180,000)
Fiscal Year 2011: ¥780,000 (Direct Cost: ¥600,000、Indirect Cost: ¥180,000)
Fiscal Year 2010: ¥780,000 (Direct Cost: ¥600,000、Indirect Cost: ¥180,000)
Fiscal Year 2009: ¥2,210,000 (Direct Cost: ¥1,700,000、Indirect Cost: ¥510,000)
|
Keywords | メニエール病 / 内リンパ水腫 / 抗利尿ホルモン / めまい発作 / 自発眼振 / 前庭機能 |
Research Abstract |
We produced a new animal model for Meniere’s disease. This model consists of hypo-function of endolymphatic sac and administration of vasopressin. This model showed larger endolymphatic hydrops than those of hypo-function of endolymphatic sac only and administration of vasopressin only. Moreover, this model showed spontaneous nystagmus and balance disorder. These results indicate that hypo-function of endolymphatic sac in combination with high plasma level of vasopressin would induce vertiginous attack of Meniere’s disease. Further, we administered V2R antagonist to the new animal model for Meniere’s disease. The animal showed decrease in endolymphatic hydrops and did not show spontaneous nystagmus or balance disorder. This result implies that V2R antagonist might be used for a treatment of Meniere’s disease.
|
Report
(5 results)
Research Products
(44 results)